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Aims: The study was undertaken to assess the efficacy of the International Ovarian Tumor Analysis (IOTA) ultrasound 
rules and the IOTA‑ Assessment of Different NEoplasias in the adneXa (ADNEX) model risk calculator in the investigation 
of ovarian masses in a semi‑rural Indian population.
Methods and Material: The study was a retrospective study. The pre‑operative ultrasound images of all patients who had 
surgery for an adnexal mass over a two year period were looked at and classified according to the IOTA‑ADNEX model calculator.
Results: There were 45 patients who had surgery for an adnexal mass of which 78% had benign findings, 15% were 
malignant, and 6% were borderline on the final histological diagnosis. After retrospectively applying the ADNEX calculator, 
the study confirmed the low false positive (4%) and false negative (2%) rates, and this was despite not having cancer antigen 
125(CA125) in hand at the time of the scan. There was one case where an adnexal lesion was classified benign on ultrasound, 
but was proven to be malignant on histology and as per the ADNEX model risk calculator.
Conclusions: The study results showed vast potential in the management of adnexal masses in countries where costs, 
healthcare providers, infrastructure, and patient follow‑up can be limited. The use of a predictive algorithm like the ADNEX 
model can help reduce anxiety, provide reassurance, and importantly avoid unwarranted surgery in patients with benign 
pathologies.
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Introduction
The International Ovarian Tumor Analysis (IOTA) group has 
shown that polytomous risk prediction for the diagnosis of 
ovarian cancer is feasible.[1] The IOTA ultrasound rules for 
ovarian masses are a simple set of ultrasound findings that 
classify persistent adnexal masses into benign (B-features), 
malignant (M-features), or inconclusive (features of both 
benign and malignant), for the latter evaluation by a specialist 
in ovarian imaging is recommended.[2]
Correctly discriminating between benign or malignant 
adnexal masses is the essential starting point for optimal 
management. Most women with an adnexal mass do not 
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have cancer.[3] Identifying women with benign pathology is 
important in order to avoid unnecessary intervention as well 
as needless costs.[4]
Aims
To assess the efficacy, false positives or false negatives, of 
IOTA ultrasound rules in classifying ovarian masses in women 
from a semi-rural Indian population attending Mahatma 
Gandhi Mission’s Hospital, Kamothe and Mahatma Gandhi 
Missions Mother and Child care Hospital, Kalamboli located 
in Navi Mumbai, Maharashtra, India.
Subjects and Methods
Ethics: Not submitted to the ethical committee as performed 
as a retrospective study.
Source of data
Women who were referred to the Department of Radio 
Diagnosis, Mahatma Gandhi Mission’s Hospital, Kamothe 
or Mahatma Gandhi Mission’s Mother and Child Care 
Hospital, Kalamboli for an adnexal mass and subsequently 
underwent surgery for the same. The study was conducted 
over a period of 27 months between May 2016 and August 
2018.
Method of study
A retrospective study was done looking at the pre-operative 
ultrasound images of all consecutive patients who underwent 
surgery for an adnexal mass at Mahatma Gandhi Mission’s 
Hospital, Kamothe or Mahatma Gandhi Mission’s Mother and 
Child Care Hospital, Kalamboli. The ultrasound machines used 
were Philips HD 11 and Phillips HD 15 and were performed by 
senior radiology residents who had at least 2 years experience 
in ultrasound scanning.
This study was carried out in a semi-rural population where 
cancer antigen-125 (CA-125) values were not available at the 
time of diagnostic imaging. Hence that parameter was not 
used at the time of calculation.
Patients who had suspected benign pathology on ultrasound 
scan (USS) generally had three follow up USS scans. They were 
operated upon only if they remained symptomatic or were 
peri menopausal with persistent clinical concern.
The reference standard was the histological classification of 
the excised adnexal mass stratified as benign, malignant, or 
borderline.
The IOTA ultrasound rules[5] are shown in Figure 1.
The ADNEX model has been used in evaluating the risk of ovarian 
cancer before surgery to help differentiate between benign, 
borderline, early and advanced stage invasive, and secondary 
metastatic tumors.[1] The risk model discriminates well between 
benign and malignant tumors and offers fair to excellent 
discrimination between the four types of ovarian malignancy.[1]
The following parameters assign a risk score on the ADNEX 
calculator [Table 1].
Data analysis
The data from ultrasound images was used to classify the 
masses using IOTA-ADNEX model calculator as benign, 
malignant, or inconclusive. It was then compared with the 
histological diagnosis. We also reviewed if there was any 
disparity among the initial ultrasound diagnosis, IOTA-ADNEX 
model evaluation diagnosis, and histological diagnosis.
Figure 1: Shows the IOTA ultrasound rules
Table 1: Showing the ADNEX model calculator
Table 1 IOTA ADNEX calculator
1. Age of the patient at examination (years)
2. Oncology center (referral center for gyn‑oncol)?
3. Maximal diameter of the lesion (mm)
4. Maximal diameter of the largest solid part (mm)
5. More than 10 locules?
6. Number of papillations (papillary projections)
7. Acoustic shadows present?
8. Ascites (fluid outside pelvis) present?
9. Serum CA‑125 (U/ml)
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Results
There were 45 patients in the aforementioned period, ages 
varying between 15 and 97 that underwent surgery for a 
persistent adnexal mass. The mean and median ages were 
38 and 35 years respectively.
Only 7 patients were post-menopausal, the remaining 
38 being pre-menopausal. There were 35 (77.8%) benign 
cases[Figures 2-4], 7 (15.5%) malignant, and 3 (6.7%) borderline 
cases on post-operative histological diagnosis. No metastatic 
ovarian lesions was identified in our study population.
Table 2 shows the various histological diagnoses obtained 
post-operatively.
Of the 7 malignant lesions, only 1 patient was post-
menopausal. The remaining 6 were pre and peri-menopausal. 
The borderline cases were all pre-menopausal.
After retrospectively applying the IOTA-ADNEX risk calculator, 
there were only 2 cases where the calculation suggested that 
the mass was malignant, but was disproved on histology to 
be benign lesions (false positives). The initial USS findings 
suggested a neoplastic mass in 1 patient and a germ cell tumor 
in the other. Both cases had ischemic necrosis on histology.
There was 1 case where the IOTA ultrasound rules suggested 
benignity, but the mass proved malignant on histology (false 
negative). This was a case of low grade serous borderline 
tumor of the ovary in a 20-year-old patient who had benign 
appearances on the initial ultrasound and had surgery due 
to being symptomatic.
When the IOTA ADNEX rules were not followed, and clinical 
diagnosis was mainly based on USS findings, there was one 
case where the USS findings suggested benign features, but 
proved to be a mucin secreting adenocarcinoma, and was 
accounted to be malignant as per the ADNEX calculation 
even without the CA125 results [Figure 5].
Discussion
The study shows that the IOTA rules and ADNEX model have a 
very high sensitivity and specificity and can be reliably applied 
in a population setting where costs are important and also 
avoids unwarranted surgery.
Table 2: Listing histological diagnosis in each category
Histological diagnosis
Benign - 35 Malignant -7 Borderline- 3
Serous cystadenoma‑7 Mucinous carcinoma‑3 Borderline serous tumor‑2
Simple cysts ‑ 6 Serous cystadeno‑carcinoma‑ 3 Borderline mucinous tumor ‑1
Hemorrhagic cysts‑ 5 Poorly differentiated adenocarcinoma ‑1
Dermoid ‑ 3
Endometrioma ‑3 
Corpus luteal cyst ‑2
Others including hemorhagic ischemic necrosis, fimbrial cyst, mucinous 
cystadenoma, fibroma, retained products of conception, oophoritis etc ‑ 9
Figure 3: Transabdominal gray scale image of a right adnexal mass lesion, 
which was well defined with echogenic strands within and on color Doppler 
imaging (not shown), showed only peripheral vascularity. It was classified 
as benign according to IOTA ADNEX calculator and proved to be oophoritis 
on histopathology
Figure 2: Transvaginal sonogram showing a well defined mass lesion in the 
adnexa containing thick non mobile echoes and echogenic areas within 
which show posterior acoustic shadowing corresponding to calcification. 
The mass was classified as benign according to IOTA ADNEX model and 
histopathology confirmed diagnosis of mature cystic teratoma
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There were one false negative (2%) and two false positives (4%) 
using the above and this was despite not having CA125 at 
hand for aiding diagnosis. This could be possibly reduced 
even further if the serum marker is available at the time of 
the scan; however adding CA-125 to clinical and ultrasound 
information does not improve discrimination of mathematical 
models between benign and malignant adnexal masses.[6] The 
use of ADNEX has the potential to improve triaging and 
management decisions and thereby reduces morbidity and 
mortality associated with adnexal pathology.[1]
It is already confirmed that in well-trained and experienced 
hands, subjective impression about an ovarian mass is 
very accurate although not all ultrasound practitioners can 
perform at this level. This is where a predictive algorithm 
like IOTA-ADNEX scoring can help less experienced 
sonographers.[7,8] In a health model where a large proportion 
of patients do not have access to expensive investigations, 
adherence to the ADNEX model was found safe to apply. 
The shortage of healthcare providers is most acute in rural 
areas; this is further compelled by the lack of infrastructure 
and resources. This simple approach would help reduce 
the anxiety, economic burden, and unnecessary surgical 
intervention for patients.
Clinical significance
The study findings were presented locally and new USS 
machines with incorporated IOTA ADNEX risk calculators 
were agreed to be brought into the Radiology department. 
This will help easy risk assessment at the time of the scan 
and provide patient reassurance as well as importantly help 
avoid unnecessary surgeries.
In rural India, where patients often have limited funds and 
long-term patient follow up is extremely difficult, ultrasound is 
clearly the imaging test of choice in a variety of circumstances.[5]
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Figure 5: Large mass lesion arising from the adnexa in a 47‑year‑old 
premenopausal woman, which was suspected to be a benign tumor of 
the ovary, however according to IOTA ADNEX model it was of malignant 
etiology. Post operatively, mucin secreting adenocarcinoma was confirmed 
on histopathology
Figure 4: Transvaginal sonogram which showed a adnexal mass lesion with 
features of endometrioma. According to IOTA ADNEX calculator it was 
benign and proved to be benign on histopathology as well 
